BVR-A has newly recognized roles in hepatic lipid regulation, as discussed below in the context of metabolic diseases, via regulation of a peroxisome proliferator activator-alpha (PPARα)-dependent pathway [62,63,64]. Here, BLVRA is linked to metabolic disease.